United States · FDA National Drug Code directory
Lofexidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71921-250_f742254f-781e-4e7a-ae0b-e79b8482980d
- Product NDC
- 71921-250
- Form
- TABLET, COATED
- Composition / generic term
- Lofexidine
- Labeler
- Florida Pharmaceutical Products, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240821
- Source listing expiry
- 20271231
Source-listed ingredients
- LOFEXIDINE HYDROCHLORIDE — .18 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (71921-250-36) / 36 TABLET, COATED in 1 BOTTLE · 71921-250-36
- 1 BOTTLE in 1 CARTON (71921-250-96) / 96 TABLET, COATED in 1 BOTTLE · 71921-250-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →